Besides NTRK1 and ALK fusions, Lung v2 NGS detected four RET fusions (4/62, 6.5%) and seven BRAF fusions (7/62, 11.3%) in our CRC cohort. This evidence concerns the gene BRAF and colorectal carcinoma.